A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.
Also called NCT01642498
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- ROX Medical, Inc.
- Registry
-
NCT01642498
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Germany, Greece, Ireland, Netherlands, Poland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01642498. Randomized; no masking; primary purpose treatment. Start 2012-09-01 (actual); primary completion 2018-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension
- Condition
- Hypertension
- Intervention (Device)
- ROX COUPLER
- Lead sponsor
- ROX Medical, Inc.
Record details
- Record id
cardio:ct-nct01642498- Content hash
4fc4be5a69cda1ec586e193a3e49a9d739f32141cf258c1e9b67ee436b09fb67